Marie Jeansson

Marie Jeansson

Forskare
E-postadress: marie.jeansson@ki.se
Besöksadress: Novum, Blickagången 6, 14157 Huddinge/Stockholm
Postadress: H7 Medicin, Huddinge, H7 ICCA Betsholtz, 171 77 Stockholm
Del av:

Artiklar

Alla övriga publikationer

Forskningsbidrag

  • Angiopoietin-2 and Lipocalin-2 as causal factors of endothelial dysfunction and diabetic complications
    EXODIAB
    1 April 2025 - 31 March 2026
  • Therapeutic intervention to slow progression of chronic kidney disease
    Knut och Alice Wallenbergs Stiftelse
    1 January 2025 - 31 December 2026
  • European Foundation for the Study of Diabetes
    1 January 2024 - 31 December 2024
  • Therapeutic intervention to slow progression of chronic kidney disease
    Novo Nordisk Foundation
    1 January 2024 - 31 December 2024
  • Angiopoietin-2 och thrombosbildning i njuren vid COVID-19
    Njurfonden
    1 January 2023 - 31 December 2023
  • Angiopoietin-2 och thrombosbildning i njuren vid COVID-19
    Njurfonden
    1 January 2022 - 31 December 2022
  • Angiopoietiners roll vid fibrosibildning
    Magn. Bergwalls Stiftelse
    1 March 2015 - 29 February 2016
  • The Angiopoietin/Tek System in Fibrotic Disease
    IGPs medel till Unga Forskare
    1 January 2015 - 31 December 2015
  • Angiopoietin/Tek systemets roll vid fibrosutveckling
    Magn. Bergwalls Stiftelse
    1 March 2014 - 28 February 2015
  • Angiopoietin/Tek systemets roll vid fibrosutveckling
    Åke Wiberg
    1 March 2014 - 28 February 2015
  • Swedish Research Council
    1 January 2013 - 31 December 2015
  • Discovery of new therapeutic targets in human disease through animal models
    Venture Sinai Women
    1 August 2012 - 31 July 2013
  • Endothelial cell glycocalyx and vascular endothelia growth factor-A (VEGF-A) in the renal glomerular barrier
    Wenner-Gren Stiftelserna
    1 January 2008 - 31 December 2008
  • Growth Factor Signaling in Renal Disease
    Vetenskapsrådet
    1 January 2008 - 31 December 2008
  • The glomerular barrier and the endothelial cell glycocaly
    Wenner-Gren Stiftelserna
    1 January 2007 - 31 December 2007

Anställningar

  • Forskare, Medicin, Huddinge, Karolinska Institutet, 2018-
  • Docent, Vaskulärbiologi, Immunology, Genetics, and Pathology, Uppsala University, 2017-2018
  • Forskare, Vaskulärbiologi, Njursjukdom, Immunologi, Genetic, and Pathology, Uppsala University, 2013-2017
  • Postdoctoral Fellow, Lunenfeld-Tanenbaum Research Institute, 2006-2013

Examina och utbildning

  • Docent, Vasculärbiologi, Immunology, genetics, and Pathology, Uppsala University, 2017
  • PhD, Njurfysiologi, Aspects of the glomerular barrier in healthy and diabetic kidneys, Neuroscience and Physiology, University of Gothenburg, 2005
  • Medicine magisterexamen, Linnaeus University, 2001

Uppdrag

  • Academic Mentor postdoctoral fellow, Roche Innovation Center, 2018-2020

Handledning

  • Handledning till doktorsexamen

    • Yuyang Miao, 2021-
    • Krishnapriya Loganathan, 2018
    • Yang Zhang, Organ-specific mechanisms of vascular development in the mesentery, 2018
    • Maria Ascencion Globisch, Inflammation and immunothrombosis in cerebral cavernous malformations, novel molecular targets for the treatment of an incurable disease, 2023

  • Handledning av postdoktorala forskare

    • Amanda Marks, 2023-

Uppdrag i kommitté

  • Medlem, American Society of Nephrology's PhD committee, American Society of Nephrology, 2016-2018
  • Medlem, Committee for Equal Opportunities, Immunology, Genetics, and Pathology, Uppsala University, 2015-2018
  • Medlem, Committee for Common Instruments, Immunology, Genetics, and pathology, Uppsala University, 2014-2018

Gästforskning och resestipendier

  • Postdoktor, Mount Sinai Hospital, 2006-2013
  • Postdoktor, University of Gothenburg, 2005-2006

Utvärdering av avhandlingsarbete

  • Milena Petkova, Examination board member, Immunology, Genetics, and Pathology, Uppsala University, Cell-autonomous and paracrine mechanisms underlaying Pik3ca-driven vascular malformations, 2024
  • Alessandra Vaccaro, Examination board member, Immunology, Genetics, and Pathology, Uppsala University, Tertiary lymphoid structures in glioblastoma, 2024
  • Federico Cantoni, Examination board member, Department of Materials Science and Engineering, Uppsala University, Fabrication advances of microvasculature models on-chip, 2023
  • Nina Daubel, Examination board member, Department of Immunology, Genetics, and Pathology, Uppsala University, Lymphatic vasculature morphogenesis: from progenitors to functional vessels, 2022
  • Frida Olsson, Examination board member, Farmaceutisk Biovetenskap, Uppsala University, Half-time seminar: Studies of cellular signaling via pathways involving steroids and tyrosine kinase receptors, 2022
  • Ana Maria Porras, Examination board member, Department of Materials Science and Engineering, Uppsala University, Micropatterning of hyaluronic acid hydrogels for in vitro models, 2022
  • Balboa Amanda, Examination board member, Department of Medical Cell Biology, Uppsala University, Experimental mechanisms in aneurysms formation, 2022
  • Minna Kihlström, External thesis reviewer, University of Oulu, Characterization of angiopoietin ligands: Role of angiopoietin-4 in retinal venous development and angiopoietin-2 variant in tumor vasculature, 2019
  • Minna Kihlström, External thesis reviewer, University of Oulu, Characterization of angiopoietin ligands: role of angiopoietin-4 in retinal venous development and angiopoietin-2 variant in tumor vasculature, 2019
  • Maria Georganaki, Examination board member, Department of Immunology, Genetics, and Pathology, Uppsala University, Vascular targeting for enhanced cancer immunotherapy, 2018
  • Anja Nitzsche, Examination board member, Department of Immunology, Genetics, and Pathology, Uppsala University, The role of Paladin in endothelial cell signaling and angiogenesis, 2016
  • Sofia Nordling, Examination board member, Immunology, Genetics, and pathology, Uppsala University, Vascular Interactions in Innate Immunity and Immunothrombosis, Models of Endothelial Protection, 2016
  • Luuk van Hooren, Examination board member, Immunology, Genetics, and Pathology, Uppsala University, Half-time seminar, 2015
  • Eric Morin, Examination board member, Immunology, Genetics, and Pathology, Uppsala University, Half-time seminar, 2015

Expert

  • Reviewer of candidates proposed for academic positions, Sakkunningutlåtande för Docentur (Jessica Cedervall), Uppsala University, 2019-2019
  • Other evaluation assignments, Kidney Week 2015 - Abstract reviewer, American Society of Nephrology, 2015-2015
  • Other evaluation assignments, Abstract Reviewer, WCN Congress, Hong Kong, World Congress of Nephrology, 2013-2013
  • Other evaluation assignments, Abstract Reviewer
  • Gordon Research Conference, Endothelial Phenotypes in Health and Disease, Gordon Research Conferences, 2012-2012

Konferenser och events

  • Muntliga presentationer av egna accepterade abstract, European Renal Association, Stockholm, Sweden, TIE2 activation promotes vascular protection of tubules to reduce PDGFB driven tubulointerstitial fibrosis in experimental chronic kidney disease«, 2024
  • Inbjuden föredragshållare, pre-meeting European Renal Association, Uppsala, Sweden, TIE2 activation promotes vascular protection of tubules to reduce PDGFB driven tubulointerstitial fibrosis in experimental chronic kidney disease«, 2024
  • Inbjuden föredragshållare, VascBio seminar
  • Uppsala Unversity, Uppsala, Sweden, TIE-ing 2gether endothelial dysfunction and fibrosis in chronic kidney disease, 2024
  • Inbjuden föredragshållare, Yale-Uppsala seminar, TIE2 activation as therapeutic intervention in chronic kidney disease (CKD), 2023
  • Inbjuden föredragshållare, Clinical Immunology seminar
  • Uppsala University, Uppsala, Sweden, Elevated Angiopoietin-2 inhibits thrombomodulin-mediated anticoagulation in critically ill COVID-19 patients, 2021
  • Inbjuden föredragshållare, SciLifeLab seminar, Uppsala, Elevated angiopoietin-2 inhibits thrombomodulin-mediated anticoagulation in critically ill COVID-19 patients, 2021
  • Inbjuden föredragshållare, Seminar
  • AstraZeneca, Gothenburg, Sweden, Tie2 signaling in chronic kidney disease, 2020
  • Inbjuden föredragshållare, Seminar
  • Integrated Cardio Metabolic Centre, Huddinge, Sweden, Endothelial-pericyte cross talk via Tie2 and Pdgfb affect capillary rarefaction and tubulointerstitial fibrosis in chronic kidney disease, 2019
  • Inbjuden föredragshållare, Seminar, Renal medicine Baxter Novum, Angiopoietin-1 and Tie2 signaling in capillary rarefaction and CKD, 2019
  • Muntliga presentationer av egna accepterade abstract, Kidney Week, American Society of Nephrology, Washington, DC, USA, Capillaries are Primary Targets in CKD and Loss of Tie2 Signaling Increases Vascular Injury, 2019
  • Inbjuden föredragshållare, Presentation
  • Karo Kidney meeting, Angiopoietin-1 and Tie2 signaling in capillary rarefaction and CKD, 2018
  • Inbjuden föredragshållare, Symposia for Erik Ilso Christensen, Aarhus University, Myths and truths in tubular handling of albumin, 2018
  • Inbjuden föredragshållare, IGP-day, Uppsala University, Sweden, 2018
  • Ordförande, Kidney Week, American Society of Nephrology, New Orleans, Ordförande for the session: Diabetsity, still a big problem?, 2017
  • Ordförande, Kidney Week, American Society of Nephrology, New Orleans, USA, Ordförande
  • Diabesity, still a big problem?, 2017
  • Inbjuden föredragshållare, Seminar
  • AstraZeneca, Angiopoietin-1/Tie2 signaling in kidney fibrosis, 2017
  • Inbjuden föredragshållare, VascBio Seminars series, Uppsala University, Angiopoietin-1 in tumor growth and metastasis, 2015
  • Inbjuden föredragshållare, Bristol University, UK, Angiopoietins - the yin and yang of vascular diseases, 2014
  • Inbjuden föredragshållare, Seminar
  • Lunenfeld-Tannenbaum Research Institute, Toronto, Canada, Angiopoietin-1 – a protective factor in diabetes, fibrosis, and tumor metastasis, 2013
  • Inbjuden föredragshållare, Seminar
  • Karolinska Institutet, Stockholm, Sweden, Angiopoietin-1 – a protective factor in diabetes, fibrosis, and tumor metastasis, 2013
  • Inbjuden föredragshållare, Seminar
  • Uppsala University, Uppsala, Sweden, Angiopoietin-1 – a protective factor in diabetes, fibrosis, and tumor metastasis, 2013
  • Inbjuden föredragshållare, Seminar
  • Sahlgrenska University Hospital, Gothenburg, Sweden, Angiopoietin-1 – a protective factor in diabetes, fibrosis, and tumor metastasis, 2012
  • Inbjuden föredragshållare, Lunenfeld-Tannenbaum Research Institute Annual Retreat, Geneva Park, Angiopoietin-1 in mouse vasculature, 2012
  • Inbjuden föredragshållare, Experimental Biology, Physiology in Focus session. San Diego, Ca, USA., New advances in the pathophysiology and treatment of chronic glomerular diseases, 2012
  • Ordförande, Gordon Research Seminars
  • Endothelial Phenotypes in Health and Disease, 2012
  • Inbjuden föredragshållare, Seminar
  • Venture Sinai Women 2, Discovery of New Therapeutic Targets in Human Disease through Animal Models
  • Future uses of Angiopoietin-1, 2012
  • Inbjuden föredragshållare, Lunch Seminars
  • Lunenfeld-Tannebaum Research institute, Toronto, Canada, Angiopoietin-1 is essential in mouse vasculature during development and in response to injury, 2011
  • Muntliga presentationer av egna accepterade abstract, Renal Week, American Society of Nephrology, Denver, CO, USA, Multiple roles for Angiopoietin-1 in renal health and diseases, 2010
  • Inbjuden föredragshållare, Renal Rounds, Toronto General Hospital, Toronto, Canada, Angiopoietins in diabetic nephropathy, 2010
  • Inbjuden föredragshållare, Renal Week, American Society of Nephrology, San Diego, CA, USA, scientific session, 2009
  • Muntliga presentationer av egna accepterade abstract, Renal Week, American Society of Nephrology, San Diego, CA, USA., Multiple roles for Angiopoietin-1 in health and disease, 2009
  • Inbjuden föredragshållare, Renal Rounds
  • Toronto general Hospital, Toronto, Canada, Angiopoietin-1 is critical for vascular development and renal repair in diabetes mellitus, 2009
  • Inbjuden föredragshållare, Annual Retreat
  • Samuel Lunenfeld Research Institute, Great Lakes, Canada, Angiopoietin-1 is critical for vascular development and renal repair in diabetes mellitus, 2009
  • Inbjuden föredragshållare, Lunch seminar
  • Lunenfeld-Tannenbaum Research Institute, Toronto, Canada, Angiopoietin-1 in glomerular function and the vasculature, 2008
  • Inbjuden föredragshållare, Renal rounds, Toronto General Hospital, Toronto, Canada, Angiopoietin-1 in vascular development and glomerular function, 2008
  • Inbjuden föredragshållare, Scandinavian Society of Nephrology, Gothenburg, Sweden, Functional properties of the glomerular barrier, 2007

Nyheter från KI

Kalenderhändelser från KI